AFT Pharmaceuticals hits $200m revenue milestone despite profit dip

AFT Pharmaceuticals hits $200m revenue milestone despite profit dip
AFT co-founder Dr Hartley Atkinson says launching into new markets takes time to reap rewards. (Image: AFT Pharmaceuticals)
Rebecca Stevenson
AFT Pharmaceuticals' co-founder, Dr Hartley Atkinson, says the firm’s choice to invest in Australia has been vindicated. The dual-listed pharmaceutical company released its results for the year ended March 31 on Thursday. While profit after tax fell to $11.9 million, revenue cracked $200m for the first time. Revenue from Australia increased by 17% to $127.1m, and operating profit leapt 65% to $25.5m. Chief executive Atkinson said AFT's investment in Australia had caused some concern, but the result proved its strate...

More Markets

THL buyout offer lifts NZX 50
Markets Market Close

THL buyout offer lifts NZX 50

Tourism Holdings helped the NZX 50 rise 1.09%.

Gregor Thompson 16 Jun 2025
THL exec enlists private equity for takeover bid
Markets

THL exec enlists private equity for takeover bid

In tandem with the offer, the consortium has amassed a 19.99% stake in THL.

Gregor Thompson 16 Jun 2025
Comvita forecasts another annual loss
Markets

Comvita forecasts another annual loss

Forecast losses don't include any impairment which is likely to be significant.

Staff reporters 16 Jun 2025
NZ sharemarket ends lower, spike in oil prices
Markets Market Close

NZ sharemarket ends lower, spike in oil prices

Australian, Hong Kong and Japanese share markets were all down after the attack.

Jamie Gray 13 Jun 2025